Yatharth Hospitals Q1 FY27: Highest Ever Revenue & Profit, Maiden 5% Interim Dividend Approved
Yatharth Hospitals reported record Q1 FY27 revenue of ₹392.7 crore, up 51% YoY, and EBITDA of ₹91.7 crore, up 39% YoY. The company approved a maiden interim dividend of 5% and launched an ESOP scheme. Newer hospitals contributed 27% to revenue, with Faridabad Sector 20 achieving breakeven in 9 months.
The announcement details record financial performance, strategic growth initiatives including new hospital contributions and capacity expansion plans, and a maiden dividend, all of which are material to investors.
The company reported record revenue and profits, significant year-on-year growth, achievement of EBITDA breakeven for a new hospital, and approval of a maiden interim dividend, all indicating strong positive performance and future outlook.
Yatharth Hospitals & Trauma Care Services Limited has reported its highest ever quarterly revenue and profits for Q1 FY27, with a record year-on-year revenue growth of 51% and EBITDA growth of 39%. The company's newer hospitals in Greater Faridabad, New Delhi, Faridabad Sector 20, and Agra collectively contributed 27% to the revenue mix. Notably, the Faridabad Sector 20 hospital achieved EBITDA breakeven within 9 months, generating a monthly revenue of ₹12-13 crore. The New Delhi hospital is nearing an ARPOB of ₹50,000, with a monthly revenue run rate of ₹8 crore, and both these hospitals have a cash and private insurance patient mix exceeding 90%. The Agra hospital, integrated last quarter, achieved a revenue run rate of ₹9-10 crore with over 20% EBITDA in its first full quarter. The upcoming Gurugram facility is expected to go live by Q1 of the next fiscal year with a potential ARPOB of over ₹50,000.
Financially, the group reported its highest ever quarterly revenue of ₹392.7 million (₹392.7 crore), a 51% increase year-on-year. Existing hospitals in Noida and Jhansi-Orchha contributed ₹286.2 million (₹286.2 crore), with an occupancy of approximately 75%. The group's ARPOB reached an all-time high of ₹34,578, up 7% year-on-year. EBITDA stood at ₹91.7 million (₹91.7 crore), and PAT was ₹45.4 million (₹45.4 crore). The Board has approved a maiden interim dividend of 5% and launched a new ESOP scheme 2026.
The company is focused on expanding its bed capacity to 5,000 beds over the next few years, with the Gurugram facility and brownfield expansions at Noida Extension and Greater Noida expected to bring the total bed capacity to over 3,200 beds. The company anticipates sustaining its growth momentum and potentially surpassing guided targets for FY27, with an expected EBITDA margin close to 24% and ARPOB growth of 9-10%.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.